Solarea Bio: Funding, Investors & Team (Sep 2026)
Solarea Bio is a biotech company focused on developing microbial therapeutics to treat chronic inflammatory conditions and improve human health. They specialize in researching and creating natural-based therapeutics to address chronic inflammation, providing hospitals with effective medicinal options. By studying genomic sequences of microbes found in healthy foods, Solarea is able to create combinations of bacteria, fungi, and prebiotic fibers that have strong anti-inflammatory properties to target specific chronic illnesses. Their research has been tested in lab and animal studies, with their first application designed to help manage metabolic processes that lead to osteopenia and osteoporosis in postmenopausal women. Founded in 2017 in Cambridge, Massachusetts by Eric Schott, Gerardo Toledo, and Jillian DeWalt, Solarea Bio offers a natural solution to improve women's health and well-being.
Solarea Bio has raised $37.1M across 5 funding rounds on record, the most recent an undisclosed round of $9.9M announced in Nov 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Solarea Bio Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Solarea Bio Funding Rounds
1 of 5 rounds was announced without a disclosed amount and is excluded from the total.
Solarea Bio raised $11.2M in an undisclosed round announced in Oct 2020.
2.6 years later, a Series B of $15.0M was announced in May 2023.
3 months later, an undisclosed round was announced in Aug 2023 with no disclosed amount.
1.1 years later, an undisclosed round of $1.0M was announced in Sep 2024.
1.2 years later, an undisclosed round of $9.9M was announced in Nov 2025.
Solarea Bio Founders and Leadership Team
Contact details for the Solarea Bio team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Solarea Bio Funding Compared to Other Biotechnology Startups
Solarea Bio's latest round of $9.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Solarea Bio in Biotechnology and Cambridge
Companies Similar to Solarea Bio
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Solarea Bio Funding FAQs
What does Solarea Bio do?
Solarea Bio is a biotech company focused on developing microbial therapeutics to treat chronic inflammatory conditions and improve human health. They specialize in researching and creating natural-based therapeutics to address chronic inflammation, providing hospitals with effective medicinal options. By studying genomic sequences of microbes found in healthy foods, Solarea is able to create combinations of bacteria, fungi, and prebiotic fibers that have strong anti-inflammatory properties to target specific chronic illnesses. Their research has been tested in lab and animal studies, with their first application designed to help manage metabolic processes that lead to osteopenia and osteoporosis in postmenopausal women. Founded in 2017 in Cambridge, Massachusetts by Eric Schott, Gerardo Toledo, and Jillian DeWalt, Solarea Bio offers a natural solution to improve women's health and well-being.
How much funding has Solarea Bio raised?
Solarea Bio has raised $37.1M across 5 rounds on record. The most recent is an undisclosed round of $9.9M announced in Nov 2025.
When did Solarea Bio last raise funding?
Solarea Bio's most recent funding round on record is an undisclosed round of $9.9M, announced in Nov 2025.
Who is the CEO of Solarea Bio?
Gerardo Toledo is listed as CEO at Solarea Bio.
Where is Solarea Bio headquartered?
Solarea Bio is based in Cambridge, Massachusetts, United States.
How many employees does Solarea Bio have?
Solarea Bio is in the 11-50 employee band.
How does Solarea Bio's funding compare to other Biotechnology startups?
Solarea Bio's latest round of $9.9M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Solarea Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Solarea Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.